Brief: Enorama Pharma Jan-March Operating Loss Widens SEK 4.4 Mln
24/05/2019 07:53
May 24 (Reuters) - Enorama Pharma AB ERMA.ST :
* JAN-MARCH OPERATING LOSS SEK 4.4 MILLION VERSUS LOSS SEK
3.0
MILLION YEAR AGO
* JAN-MARCH NET SALES SEK 386,000 VERSUS SEK 1.6 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr9P0blV
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO